Expert Opinion
Opinions and insights from thought leaders and clinicians on the front lines of care.
Commentary
Opinions and ideas from experts in oncology
Accumulating Data Support Bevacizumab Use for Recurrent High-Grade Glioma
2012 May 16, Patrick Morris, MD
EXPERT
Patrick Morris, MD
Interviews
Discussions with top medical experts
Update on Triple Negative Breast Cancer
Interview by L Scott Zoeller. 2012 May 22, Kathy Miller, MD
My Approach
Experts share their viewpoints on the management of difficult or controversial clinical scenarios
My Approach to Chronic Myeloid Leukemia
Interview by L Scott Zoeller. 2012 Apr 3, Tim Hughes, MD
The Lancet Oncology: Comment
Expert commentaries that accompany original articles published in The Lancet Oncology
Personalised Medicine in Oncology: Questions for the Next 20 Years
Lancet Oncol. 2012 May 1;13(5):448-449, J-Y Blay, et al
Seminal Articles
The definitive list of must-read articles for practicing oncologists
Seminal Articles—Kidney Cancer
2012 Apr 11, Eric Jonasch, MD, et al
EXPERT
Eric Jonasch, MD
Ask the Expert
Leading experts answer clinical questions submitted by OncologySTAT users
IgM Spike After Rituximab Monotherapy in Waldenström’s
2012 Jan 30, Andre Goy, MD
EXPERT
Andre Goy, MD
Cancer Policy Forum
Behind-the-headlines perspectives from COA on health care reform and cancer-related drug legislation
How to Fix Cancer Drug Shortages
Community Oncology Alliance. 2012 Mar 14, Patrick Cobb, MD; Ted Okon
EXPERT
Patrick W. Cobb, MD, FACP
EXPERT
Ted Okon
Cancer Policy Forum
Behind-the headlines perspectives on health care reform, cancer-related drug legislation, and other topics likely to have a major impact on oncology practice.
